is considered as an essential pathophysiologic factor and target in the context of MI. However, numerous clinical trials of post-MI immunomodulating/anti-inflammatory targets have shown inconclusive and controversial results. [3] Hence, studies are needed to understand what, how, and in what time frame the immune system is activated, providing a basis for modulating the immune-inflammatory mechanisms underlying the myocardial healing process.Cardiac immune cells are highly heterogeneous, and their activation in the progression of MI is distinct. [4] Some cell types such as macrophages and monocytes, which play a central role in multiple pathophysiological processes of MI, are comprised of diverse subsets because of their different origins and functions. [5] However, much less is known about the complex diversity of cardiac immunity. Recently, an innovative high-throughput technology, single-cell RNA sequencing (scRNA-seq), has increased our understanding of the major immune cell types in the mammalian heart and their dynamics during disease progression. Dick et al. [6] identified functionally distinct cardiac macrophage subsets that are hierarchically replaced by monocytes after infarction. Vafadarnejad et al. [7] revealed temporal diversity and local transition of neutrophils within the ischemic tissue. Moreover, Farbehi et al. [8] described the heterogeneity and dynamics of several cardiac immune Myocardial infarction (MI) is strongly associated with the temporal regulation of cardiac immunity. However, a variety of current clinical trials have failed because of the lack of post-MI immunomodulating/anti-inflammatory targets. Single-cell RNA sequencing analysis of the cardiac Cd45 + immune cell at 0, 3, 7, and 14 d after injury in a mouse left anterior descending coronary artery ligation model is performed. Major immune cell populations, distinct subsets, and dynamic changes are identified. Macrophages (Mø) are most abundant, peaking at 3 d after infarction. Mø-5 and Mø-6 are the predominant infiltrated subsets at this time point, with strong expression of inflammatory factors. Further analysis demonstrates that suppressing these sets attenuated pathological MI progression by preventing subsequent leukocyte extravasation and adverse remodeling. Abundant apoptotic neutrophils and a profibrotic macrophage subset on days 7 and 14, respectively, are also detected. These results provide a basis for developing cell type-and time-specific interventions in MI.The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/smtd.202100752.